BioCentury
ARTICLE | Clinical News

Lidakol n-docosanol 10 percent cream: Began European Phase III trials

May 16, 1994 7:00 AM UTC

Lidak Pharmaceuticals (LDAKA), La Jolla Product: Lidakol n-docosanol 10 percent cream Indication: Herpes cold sores Status: Partner Yamanouchi began European Phase III trials in 400 patients to compar...